3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
52
Carcinoma, Renal Cell
25
Liver Neoplasms
23
Neoplasms
19
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
16
Kidney Neoplasms
11
Leukemia, Myeloid, Acute
9
Melanoma
8
Glioblastoma
8
Sarcoma
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Brain Neoplasms
7
Thyroid Neoplasms
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Gliosarcoma
5
Urinary Bladder Neoplasms
4
Recurrence
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia
4
Carcinoma
4
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leiomyosarcoma
3
Interventions
Carboplatin
6
Paclitaxel
5
Taxes
3
Docetaxel
3
Cisplatin
3
Gemcitabine
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Bevacizumab
2
talimogene laherparepvec
1
saracatinib
1
romidepsin
1
rilotumumab
1
ganitumab
1
Zoledronic Acid
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Therapeutics
1
Talc
1
Surveys and Questionnaires
1
Spectrum Analysis
1
Sodium Chloride
1
Pemetrexed
1
Nivolumab
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Immunohistochemistry
1
Imatinib Mesylate
1
Gefitinib
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pleural Effusion, Malignant
×
Sorafenib
×
Clear all
No trials found.